ZA997794B - Prostaglandin product. - Google Patents
Prostaglandin product.Info
- Publication number
- ZA997794B ZA997794B ZA9907794A ZA997794A ZA997794B ZA 997794 B ZA997794 B ZA 997794B ZA 9907794 A ZA9907794 A ZA 9907794A ZA 997794 A ZA997794 A ZA 997794A ZA 997794 B ZA997794 B ZA 997794B
- Authority
- ZA
- South Africa
- Prior art keywords
- prostaglandin product
- prostaglandin
- product
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9278698P | 1998-07-14 | 1998-07-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA997794B true ZA997794B (en) | 2001-01-02 |
Family
ID=22235155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9907794A ZA997794B (en) | 1998-07-14 | 1999-12-21 | Prostaglandin product. |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1011728B1 (xx) |
JP (2) | JP2002520368A (xx) |
KR (1) | KR20010021835A (xx) |
CN (1) | CN1146423C (xx) |
AR (1) | AR019773A1 (xx) |
AT (1) | ATE285795T1 (xx) |
AU (1) | AU743607B2 (xx) |
BR (1) | BR9906597A (xx) |
CA (1) | CA2295512C (xx) |
DE (1) | DE69922916T2 (xx) |
ES (1) | ES2234270T3 (xx) |
HK (1) | HK1028563A1 (xx) |
PT (1) | PT1011728E (xx) |
TW (1) | TW585769B (xx) |
WO (1) | WO2000003736A1 (xx) |
ZA (1) | ZA997794B (xx) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE285795T1 (de) * | 1998-07-14 | 2005-01-15 | Alcon Mfg Ltd | Polypropylenbasierte behälter für prostaglandin- enthaltende produkte |
EP1159266B1 (en) | 1999-03-05 | 2004-11-03 | Duke University | C-16 unsaturated fp-selective prostaglandins analogs |
ATE455098T1 (de) * | 1999-09-10 | 2010-01-15 | Taisho Pharmaceutical Co Ltd | Prostaglandin-derivate |
US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
DE60143615D1 (de) * | 2000-09-13 | 2011-01-20 | Asahi Glass Co Ltd | Augentropfen |
WO2002022106A2 (en) * | 2000-09-14 | 2002-03-21 | Novartis Ag | Stable ophthalmic preparation |
AU2003221379A1 (en) | 2002-03-18 | 2003-09-29 | Santen Pharmaceutical Co., Ltd. | High-temperature-sterilizable instillator |
DK1532981T3 (da) * | 2002-08-23 | 2008-01-28 | Santen Pharmaceutical Co Ltd | Stabile öjendråber, der indeholder latanoprost som den aktive bestanddel |
ATE450264T1 (de) * | 2003-07-31 | 2009-12-15 | Santen Pharmaceutical Co Ltd | Prostaglandin enthaltendes produkt |
CN101072568A (zh) * | 2004-12-09 | 2007-11-14 | 参天制药株式会社 | 含有分子内具有氟原子的前列腺素的制品 |
KR101283874B1 (ko) * | 2004-12-24 | 2013-07-08 | 산텐 세이야꾸 가부시키가이샤 | 프로스타글란딘 F2α유도체 함유 제품 |
JP4753178B2 (ja) * | 2004-12-24 | 2011-08-24 | 参天製薬株式会社 | プロスタグランジンF2α誘導体含有製品 |
JP5252787B2 (ja) * | 2005-08-02 | 2013-07-31 | 参天製薬株式会社 | 熱的に不安定な薬物の分解抑制方法 |
ES2460967T3 (es) * | 2005-08-02 | 2014-05-16 | Santen Pharmaceutical Co., Ltd. | Método para la prevención de la degradación de una sustancia térmicamente inestable |
BRPI0708891A2 (pt) * | 2006-03-13 | 2011-06-28 | R Tech Ueno Ltd | composição aquosa |
CN105566192B (zh) * | 2006-10-02 | 2019-01-22 | 于崇曦 | 具有快速皮肤穿透速度的带正电荷的水溶性的前列腺素及相关化合物的前药 |
US8455513B2 (en) | 2007-01-10 | 2013-06-04 | Aerie Pharmaceuticals, Inc. | 6-aminoisoquinoline compounds |
EP2123278B1 (en) * | 2007-02-07 | 2013-01-09 | Teika Pharmaceutical Co., Ltd. | Eye drop preparation comprising latanoprost |
KR101529093B1 (ko) * | 2007-08-29 | 2015-06-16 | 와카모토 세이야꾸 가부시끼가이샤 | 라타노프로스트 함유 수성 의약 조성물 |
BRPI0818459A2 (pt) * | 2007-10-16 | 2015-04-14 | Sun Pharma Advanced Res Co Ltd | Composição farmacêutica adequada para uso oftálmico. |
TWI544927B (zh) * | 2008-03-17 | 2016-08-11 | 愛爾康研究有限公司 | 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物 |
JP2009256281A (ja) * | 2008-04-21 | 2009-11-05 | Teika Seiyaku Kk | イソプロピルウノプロストン含有点眼剤組成物 |
EP2127638A1 (en) * | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Method and composition for treating ocular hypertension and glaucoma |
US8450344B2 (en) | 2008-07-25 | 2013-05-28 | Aerie Pharmaceuticals, Inc. | Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
US20100087540A1 (en) * | 2008-10-07 | 2010-04-08 | R-Tech Ueno, Ltd. | Pharmaceutical composition |
AU2010220061A1 (en) * | 2009-02-20 | 2010-09-10 | Micro Labs Limited | Storage stable prostaglandin product |
ES2553827T3 (es) | 2009-05-01 | 2015-12-14 | Aerie Pharmaceuticals, Inc. | Inhibidores de mecanismo doble para el tratamiento de enfermedad |
DE102009021372A1 (de) * | 2009-05-14 | 2010-11-18 | Ursapharm Arzneimittel Gmbh | Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung |
WO2011027778A1 (ja) * | 2009-09-01 | 2011-03-10 | 株式会社アールテック・ウエノ | 高眼圧症および緑内障処置のための眼局所投与用組成物 |
CN102481301A (zh) | 2009-09-17 | 2012-05-30 | 千寿制药株式会社 | 含有拉坦前列素的水性滴眼剂以及抑制拉坦前列素对树脂的吸附的方法 |
US8658676B2 (en) | 2010-10-12 | 2014-02-25 | The Medicines Company | Clevidipine emulsion formulations containing antimicrobial agents |
DK2627173T4 (en) * | 2010-10-12 | 2018-10-22 | Chiesi Farm Spa | CLEVIDIPINE EMULSUM FORMULATIONS CONTAINING ANTIMICROBIANTS |
EP2452669A1 (en) | 2010-10-29 | 2012-05-16 | Omnivision GmbH | Ophthalmic composition |
EP2567689A1 (en) | 2011-09-12 | 2013-03-13 | Visiotact Pharma | Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid |
ES2852377T3 (es) | 2013-03-15 | 2021-09-13 | Aerie Pharmaceuticals Inc | Sales dimesilato de 4-(3-amino-1-(isoquinolin-6-ilamino)-1-oxopropan-2-il)bencilo, sus combinaciones con prostaglandinas y el uso de las mismas en el tratamiento de trastornos oculares |
EP3093019B1 (en) | 2014-01-10 | 2021-05-26 | Santen Pharmaceutical Co., Ltd | Pharmaceutical composition containing pyridylamino acetic acid compound |
SG11201605532YA (en) * | 2014-01-10 | 2016-08-30 | Santen Pharmaceutical Co Ltd | Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition |
WO2016093345A1 (ja) * | 2014-12-12 | 2016-06-16 | 興和株式会社 | 組成物 |
US9643927B1 (en) | 2015-11-17 | 2017-05-09 | Aerie Pharmaceuticals, Inc. | Process for the preparation of kinase inhibitors and intermediates thereof |
KR102568079B1 (ko) | 2016-08-31 | 2023-08-17 | 에어리 파마슈티컬즈, 인코포레이티드 | 안과용 조성물 |
CA3057872A1 (en) | 2017-03-31 | 2018-10-04 | Aerie Pharmaceuticals, Inc. | Aryl cyclopropyl-amino-isoquinolinyl amide compounds |
US11427563B2 (en) | 2018-09-14 | 2022-08-30 | Aerie Pharmaceuticals, Inc. | Aryl cyclopropyl-amino-isoquinolinyl amide compounds |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA88963B (en) * | 1987-02-27 | 1989-11-29 | Allergan Inc | Prostaglandins useful for lowering intraocular pressure |
JP3256997B2 (ja) * | 1990-08-30 | 2002-02-18 | 千寿製薬株式会社 | 安定な水性製剤 |
US5425480A (en) * | 1992-12-17 | 1995-06-20 | Ryder International Corporation | Dose dispenser having a molded plastic housing with a cavity and a metallic foil wall covering the cavity |
US5631287A (en) * | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
JPH09124484A (ja) | 1995-10-27 | 1997-05-13 | Schering Purau Kk | 点眼剤 |
ATE285795T1 (de) * | 1998-07-14 | 2005-01-15 | Alcon Mfg Ltd | Polypropylenbasierte behälter für prostaglandin- enthaltende produkte |
-
1999
- 1999-06-15 AT AT99931790T patent/ATE285795T1/de active
- 1999-06-15 DE DE69922916T patent/DE69922916T2/de not_active Expired - Lifetime
- 1999-06-15 KR KR1020007000399A patent/KR20010021835A/ko not_active Application Discontinuation
- 1999-06-15 CN CNB998007757A patent/CN1146423C/zh not_active Ceased
- 1999-06-15 AU AU48220/99A patent/AU743607B2/en not_active Ceased
- 1999-06-15 EP EP99931790A patent/EP1011728B1/en not_active Revoked
- 1999-06-15 ES ES99931790T patent/ES2234270T3/es not_active Expired - Lifetime
- 1999-06-15 BR BR9906597-5A patent/BR9906597A/pt not_active Application Discontinuation
- 1999-06-15 CA CA002295512A patent/CA2295512C/en not_active Expired - Fee Related
- 1999-06-15 PT PT99931790T patent/PT1011728E/pt unknown
- 1999-06-15 WO PCT/US1999/013276 patent/WO2000003736A1/en not_active Application Discontinuation
- 1999-06-15 JP JP2000559870A patent/JP2002520368A/ja active Pending
- 1999-06-22 TW TW088110467A patent/TW585769B/zh not_active IP Right Cessation
- 1999-07-13 AR ARP990103414A patent/AR019773A1/es unknown
- 1999-12-21 ZA ZA9907794A patent/ZA997794B/xx unknown
-
2000
- 2000-12-13 HK HK00108004A patent/HK1028563A1/xx not_active IP Right Cessation
-
2010
- 2010-01-28 JP JP2010017455A patent/JP2010100652A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU4822099A (en) | 2000-02-07 |
BR9906597A (pt) | 2000-07-18 |
HK1028563A1 (en) | 2001-02-23 |
CA2295512C (en) | 2009-05-26 |
DE69922916D1 (de) | 2005-02-03 |
AU743607B2 (en) | 2002-01-31 |
WO2000003736A1 (en) | 2000-01-27 |
PT1011728E (pt) | 2005-03-31 |
DE69922916T2 (de) | 2005-06-09 |
ES2234270T3 (es) | 2005-06-16 |
EP1011728B1 (en) | 2004-12-29 |
CA2295512A1 (en) | 2000-01-14 |
CN1272063A (zh) | 2000-11-01 |
CN1146423C (zh) | 2004-04-21 |
ATE285795T1 (de) | 2005-01-15 |
EP1011728A1 (en) | 2000-06-28 |
JP2002520368A (ja) | 2002-07-09 |
AR019773A1 (es) | 2002-03-13 |
JP2010100652A (ja) | 2010-05-06 |
TW585769B (en) | 2004-05-01 |
KR20010021835A (ko) | 2001-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA997794B (en) | Prostaglandin product. | |
EG24814A (en) | Novel compounds. | |
DE69941083D1 (en) | 12,13-cyclopropan-epothilonderivate | |
ZA996185B (en) | Sulfanylsilanes. | |
ZA200005136B (en) | Dihydropyrimides. | |
ZA989767B (en) | Novel compounds. | |
ZA99254B (en) | Benzosulfone derivatives. | |
ZA200108736B (en) | Snack product. | |
ZA991272B (en) | Novel thiobenzamides. | |
ZA99680B (en) | Ester compounds. | |
ZA992443B (en) | Hydroxy-methyl-hexanones. | |
ZA98295B (en) | Food product. | |
ZA991550B (en) | Cyclohexanediole derivatives. | |
GB9824152D0 (en) | New product | |
AU3198299A (en) | Multi-carotenoid product | |
ZA9811758B (en) | Novel compounds. | |
ZA993123B (en) | Trisresorcinyltriazines. | |
ZA995325B (en) | Methylcyclotetradec-5-en-1-ones. | |
ZA9811503B (en) | Novel compounds. | |
ZA992899B (en) | Novel compound. | |
AU2964899A (en) | 2,4-dioxo-5-arylidenimino-1,3-pyrimidines | |
ZA98868B (en) | Novel compounds. | |
ZA98413B (en) | Food product. | |
ZA992493B (en) | Multiple zone member. | |
ZA993642B (en) | Ester compounds. |